Michelle Collazo Castro
Dermatology · Manati, PRNPI 1669666137
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,322 of the $1,691 with a category attached, or 78.2%. AbbVie accounts for 66.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $667 and has fallen 67.3% since, to $219 in 2025. That places this record below the midpoint for dermatology clinicians in PR, where the typical reported total is $1,906.
Across 33 payments — averaging $51.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$380
- Sanofi$123
- E.r. Squibb & Sons, L.L.C.$25
- Eli Lilly Export S.A. Puerto Rico Branch$23
- PBG Puerto Rico LLC$21
What the payments were for
- Food & beverage$1,32278%
- Education$36922%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $1,118 |
| Johnson & Johnson(2 entities) | 5 | $380 |
| Sanofi | 2 | $123 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $23 |
| PBG Puerto Rico LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,691 in reported general payments places this provider in the 45th percentile of 108 dermatology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 18 | $373,779 |
| Dupixent PenDupilumab | 15 | $57,688 |
| Desonide | 384 | $24,873 |
| Fluorouracil | 298 | $24,055 |
| Mometasone Furoate | 406 | $14,431 |
| Metronidazole | 241 | $13,615 |
| SoolantraIvermectin | 17 | $12,565 |
| Fluocinonide | 151 | $12,444 |
| Ketoconazole | 362 | $11,147 |
| Ciclopirox | 205 | $10,040 |
| Ivermectin | 51 | $9,639 |
| Halobetasol Propionate | 51 | $5,718 |
| Econazole Nitrate | 110 | $5,663 |
| Betamethasone Dipropionate | 114 | $5,655 |
| Betamethasone Valerate | 102 | $4,487 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Manati
- Lymarie Aguila GonzalezManati$5K
- Jose Gonzalez ChavezSan Juan$248K
- Rafael Martin GarciaSan Juan$199K
- Noelani Gonzalez-OrtizSan Juan$154K
- Alma Cruz SantanaCarolina$74K
- Eneida de la TorreBayamon$39K
- Samuel SanchezCaguas$25K
- Elena Montalvan MiroSan Juan$20K
- Luis Ortiz EspinosaBayamon$18K
- Hiram RuizArecibo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.